All published data cited is for scientific reference only and does not constitute a product claim or medical advice
Patients who continued semaglutide 2.4 mg at week 20 lost an additional 7.9% of body weight by week 68
9, 2025, the FDA has received 1,424 reports of adverse events associated with compounded GLP-1 drugs, including reports of hundreds of hospitalizations and 23 deaths
Rothman stressed that the medications are not a shortcut
However, they do explain how the drugs work, research-backed pros and cons, and "if they're going to choose them, (how) to take them in a way that provides the best chance of long-term success," said Bob Wright, a longtime health educator at Hilton Head Health
Because of these effects, many people on the drugs begin to lose weight